[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551283":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":54,"collaborators":56,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":14,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":12,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":12,"overallStatus":39,"whyStopped":12,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Duke University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","NO_INTERVENTION","Control clinicians will continue usual care.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"CO-LEAD","ACTIVE_COMPARATOR","CO-LEAD clinicians will receive training in the intervention.",[18],"Behavioral: CO-LEAD",[20],{"type":21,"name":14,"description":22,"armGroupLabels":23,"otherNames":12},"BEHAVIORAL","The investigators will provide clinicians with a program to teach them to use effective communication strategies with patients to review real-time pharmacy refill data and the DOSE-Nonadherence-SLE survey, and engage and formulate solutions to adherence barriers together. The study team will provide the clinician intervention training in-person or virtually and will include didactics, demonstration, and practice that include two one-hour sessions one month apart. After training, CO-LEAD clinicians will be encouraged to incorporate the intervention in regular clinic visits with all patients.",[14],[25],{"name":26,"affiliation":5,"role":27},"Kai Sun, MD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":12,"email":32},"CONTACT","919- 681- 7417","kai.sun@duke.edu",{"name":34,"role":30,"phone":35,"phoneExt":12,"email":36},"Kathyrn Pollak, PhD","919-681-4757","Kathyrn.Pollak@duke.edu",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Durham","North Carolina","27710","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-78.89862,35.99403,{"lat":49,"lon":48},[52],{"name":53,"role":30,"phone":12,"phoneExt":12,"email":32},"Kai Sun",{"type":55,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[57],{"name":58,"class":59},"National Institute on Minority Health and Health Disparities (NIMHD)","NIH","100551283","intervention-to-improve-communication-and-medication-adherence-in-lupus-100551283",false,"NCT06458075","Intervention to Improve Communication and Medication Adherence in Lupus","Intervention to Improve Patient-provider Communication and Medication Adherence Among Patients With Systemic Lupus Erythematosus (SLE)","Clinician Inclusion Criteria:\n\n1. Adult rheumatology attendings, advanced practice providers, and fellows at the two academic institutions\n2. Clinicians who have ambulatory rheumatology care at least ½ day per week\n\nClinician Exclusion Criteria:\n\n1. Clinicians at Duke University who were involved in the investigators' pilot work\n2. Clinicians with an anticipated departure from the institution in the 12 months following enrollment\n\nPatient Inclusion Criteria:\n\n1. 18 years or older\n2. English-speaking, able to provide consent\n3. Diagnosed with SLE and receiving care with enrolled clinicians\n4. Prescribed at least one SLE medication, and filling their SLE mediations at a pharmacy linked to Surescripts reporting visible in Epic EMR.\n\nPatient Exclusion Criteria:\n\n1. Non-English speakers\n2. Patients who are prescribed only corticosteroids for SLE\n3. Patients who are accompanied by third-party member that is not willing or able to remain in the waiting room during the patient's visit and\n\n   * Does not wish to be audio recorded\n   * A minor without a parental\u002Flegal guardian and\u002For\n   * Unable to give consent","ALL","18 Years","90 Years",{"count":71,"type":72},480,"ESTIMATED","INTERVENTIONAL",[75],"NA","CO-LEAD is an intervention to improve patient-provider communication and medication adherence among patients with systemic lupus erythematosus (SLE).\n\nThe purpose of this study is to optimize the culturally appropriate delivery and test the effect of the CO-LEAD intervention, which includes the following:\n\n1. clinicians will be provided with a program to teach them to use effective communication strategies with patients to review real-time pharmacy refill date, engage and formulate solutions to adherence barriers, and collaboratively overcome adherence barriers.\n2. use of a reliable and valid patient-reported measure of the extent of and reasons for nonadherence that helps patients identify and communicate their adherence barriers with clinicians proactively, efficiently, and comprehensively.",[78],"Systemic Lupus Erythematosus","2026-08-13",{"date":81,"type":82},"2026-08-17","ACTUAL",{"date":84,"type":82},"2024-07-01",{"date":86,"type":72},"2028-12",{"name":5,"class":6},1]